Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial.

M, Natsuaki; K, Kozuma; T, Morimoto; K, Kadota; T, Muramatsu; Y, Nakagawa; T, Akasaka; K, Igarashi; K, Tanabe; Y, Morino; T, Ishikawa; H, Nishikawa; M, Awata; M, Abe; H, Okada; Y, Takatsu; N, Ogata; K, Kimura; K, Urasawa; Y, Tarutani; N, Shiode; T, Kimura

doi:10.1016/j.jacc.2013.04.045

Public

Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial.

Shared by NobleBlocks on May 15, 2013 • 12:00 AM UTC

Authors:

Natsuaki M

Kozuma K

Morimoto T

Abstract

Objectives NEXT (NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-Eluting Stent Trial) was designed for evaluating the noninferiority of a biolimus-eluting stent (BES) relative to an everolimus-eluting stent (EES) in terms of target lesion revascularization (TLR) at 1 year.Background Efficacy...

Discussions